Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View Raised
12:26pm, Tuesday, 05'th Nov 2024
Vertex's third-quarter 2024 earnings and revenues beat estimates. The company raises its full-year product revenue guidance.
5 Top Stocks to Buy in November
09:32am, Tuesday, 05'th Nov 2024
From blue chip dividend stocks to industry-leading growth stocks, there are plenty of bargains in today's market if you know where to look.
My 2 Favorite Growth Stocks to Buy Hand Over Fist in November
05:53am, Tuesday, 05'th Nov 2024
The sky's the limit for these stocks.
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2024 Earnings Call Transcript
08:42pm, Monday, 04'th Nov 2024
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Susie Lisa - Senior Vice President, Investor Relations Dr. Reshma K
Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates
06:15pm, Monday, 04'th Nov 2024
Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $4.38 per share, beating the Zacks Consensus Estimate of $4.13 per share. This compares to earnings of $4.08 per share a year ago.
Vertex Pharmaceuticals Beats Third-Quarter Estimates As Pain Treatment Looms
04:25pm, Monday, 04'th Nov 2024
Vertex Pharmaceuticals beat third-quarter expectations on Monday. Though the company raised its sales outlook, Vertex stock was muted.
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
04:04pm, Monday, 04'th Nov 2024
Vertex Pharmaceuticals raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments.
Vertex Reports Third Quarter 2024 Financial Results
04:01pm, Monday, 04'th Nov 2024
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2024, and raised its full-year produ
Prediction: Vertex Pharmaceuticals (VRTX) Could Be The Next Stock Split Stock
09:30am, Thursday, 31'st Oct 2024
Companies announce stock splits all the time, and so far this year a number of high profile companies have divvied up their shares into smaller slices.
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today
06:56pm, Wednesday, 30'th Oct 2024
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $475.08, representing a +1% change from its previous close.
Vertex (VRTX) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:20am, Wednesday, 30'th Oct 2024
Besides Wall Street's top -and-bottom-line estimates for Vertex (VRTX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
12:20pm, Tuesday, 29'th Oct 2024
VRTX's revenues in the third quarter of 2024 are likely to have been driven by the robust sales of its lead CF product, Trikafta/Kaftrio.
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note
07:06pm, Monday, 28'th Oct 2024
Vertex Pharmaceuticals (VRTX) closed at $476.37 in the latest trading session, marking a -0.28% move from the prior day.
Top Stocks To Buy Now? 2 Biotech Stocks To Watch
11:15am, Monday, 28'th Oct 2024
Biotech stocks to keep an eye on in the stock market right now.
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:05am, Monday, 28'th Oct 2024
Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
